Tatsis Ourania bought VRTX

February 12, 2025 · Form 4 insider transaction

Tatsis Ourania bought 6,211 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

6,211

Price

$0.00

Total value

N/A

InsiderTatsis Ourania

RoleDirector

CompanyVertex Pharmaceuticals Incorporated (VRTX)

SecurityCommon Stock

Transaction codeA: Grant or award

Transaction dateFebruary 12, 2025

Filing dateFebruary 14, 2025

Shares owned after70,232

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Restricted stock unit award that vests in installments beginning on 02/24/2026.

View the original Form 4 on SEC EDGAR